Breast Carcinoma Shown on 99mTc-HYNIC-TOC Study Performed to Evaluate Tumor-Induced Osteomalacia.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Feb 2022
01 Feb 2022
Historique:
pubmed:
19
8
2021
medline:
13
1
2022
entrez:
18
8
2021
Statut:
ppublish
Résumé
A 74-year-old woman with a history of suspected tumor-induced osteomalacia underwent 99mTc-HYNIC-TOC scintigraphy to search potential culprit tumor. The images showed one in the middle shaft of left femur without corresponding morphology change on the CT portion of the subsequent SPECT/CT images. The patient declined surgical exploration of the left femur. Another activity was in the right breast, which was resected and pathologically confirmed as breast carcinoma. Postsurgically, the patient's symptoms were not improved. Four years later, a repeat 99mTc-HYNIC-TOC scintigraphy showed more prominent activity in the left femur with gross abnormality on the corresponding CT images.
Identifiants
pubmed: 34406185
doi: 10.1097/RLU.0000000000003861
pii: 00003072-202202000-00031
doi:
Substances chimiques
Organotechnetium Compounds
0
technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotide
0
Octreotide
RWM8CCW8GP
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
197-199Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Chen L, Li F, Zhuang H, et al. Cardiac pheochromocytomas detected by Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) scintigraphy. Clin Nucl Med . 2007;32:182–185.
Chen L, Li F, Zhuang H, et al. 99m Tc-HYNIC-TOC scintigraphy is superior to 131 I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma. J Nucl Med . 2009;50:397–400.
Ding J, Cheng X, Hou G, et al. Adrenal Castleman disease on 99m Tc-HYNIC-TOC scan and FDG PET/CT. Clin Nucl Med . 2021;46:71–73.
Pan Q, Zhang X, Luo Y, et al. A mixed variant of Castleman disease detected by somatostatin receptor scintigraphy with 99m Tc-HYNIC-TOC and 18 F-FDG PET/CT. Clin Nucl Med . 2019;44:164–166.
Jing H, Li F, Zhuang H, et al. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide ( 99m Tc-HYNIC-TOC) whole body scan. Eur J Radiol . 2013;82:2028–2034.
Jing H, Li F, Zhong D, et al. 99m Tc-HYNIC-TOC ( 99m Tc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO). Clin Nucl Med . 2013;38:664–667.
Shi X, Jing H, Li F, et al. 99m Tc-HYNIC-TOC in the evaluation of recurrent tumor-induced osteomalacia. Clin Nucl Med . 2019;44:209–213.
Jin X, Jing H, Li F, et al. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99m Tc-hydrazinonicotinyl-Tyr3-octreotide ( 99m Tc-HYNIC-TOC) scintigraphy. Clin Nucl Med . 2013;38:922–924.
Zhang J, Zhu Z, Zhong D, et al. 68 Ga DOTATATE PET/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med . 2015;40:642–646.
Reubi JC, Waser B, Foekens JA, et al. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer . 1990;46:416–420.
Savelli G, Zaniboni A, Bertagna F, et al. Peptide receptor radionuclide therapy (PRRT) in a patient affected by metastatic breast cancer with neuroendocrine differentiation. Breast Care (Basel) . 2012:408–410.
Dalm SU, Melis M, Emmering J, et al. Breast cancer imaging using radiolabelled somatostatin analogues. Nucl Med Biol . 2016;43:559–565.